DMOG (Dimethyloxallyl Glycine) 是具有细胞渗透和竞争性 HIF-PH 抑制剂，可导致蛋白 HIF-1α 的积聚和稳定。DMOG 是 α-ketoglutarate 的类似物并且可以抑制 α-KG 依耐性羟化酶。DMOG 是一种促血管生成剂，在结肠炎和腹泻动物模型中起保护作用。DMOG 可以诱导细胞自噬 (autophagy).
| 生物活性 |
DMOG (Dimethyloxallyl Glycine) is a cell permeable and competitive inhibitor of HIF-PH, which results in HIF-1α stabilisation and accmulation in vitro and in vivo. DMOG is an α-ketoglutarate analogue and inhibits α-KG-dependent hydroxylases. DMOG acts as a pro-angiogenic agent and plays a protective role in experimental model of colitis and diarrhoea via HIF-1 related signal. DMOG induces cell autophagy. |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 体外研究 |
DMOG efficiently suppresses hydroxyproline synthesis in intact cells, but shows only weakly active in the microsomal system. DMOG reduces FGF-2-induced proliferation and cyclin A expression by inhibiting prolyl hydroxylase activity in HPASMC. |
||||||||||||||||
| 体内研究 |
DMOG inhibits endogenous HIF inactivation, and induces angiogenesis in ischaemic skeletal muscles of mice. Up-regulation of hypoxia-inducible factor-1α by DMOG enhances the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats.
|
||||||||||||||||
| 分子式 |
C6H9NO5
|
||||||||||||||||
| 分子量 |
175.14
|
||||||||||||||||
| CAS号 |
89464-63-1
|
||||||||||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
| 储存方式 |
|
||||||||||||||||
| 溶解性数据 |
In Vitro:
DMSO : ≥ 50 mg/mL (285.49 mM) H2O : 50 mg/mL (285.49 mM; Need ultrasonic) * "≥" means soluble, but saturation unknown. 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：
——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；
以下溶剂前显示的百
|
||||||||||||||||
| 科研文献 |
|
纯度： 98%
关注我们
获得KKL MED 最新资讯
客服小K 
客服小K
Data Sheet